, Tracking Stock Market Picks
Enter Symbol:
Autodesk, Inc. (ADSK) [hlAlert]

up 36.05 %

Autodesk, Inc. (ADSK) upgraded to Buy by Jefferies

Posted on: Friday,  Mar 1, 2013  8:25 AM ET by Jefferies

Jefferies rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 03/01/2013, when the stock price was $36.75. Since
then, Autodesk, Inc. has gained 36.05% as of 11/20/2015's recent price of $50.00.
If you would have followed this Jefferies's recommendation on ADSK, you would have gained 36.05% of your investment in 994 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/1/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  2.84 %
1 Month up  9.64 %
3 Months up  25.03 %
1 YTD up  29.90 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2012 8:25 AM Hold
8/6/2010 9:25 AM Hold
28.83 31.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy